Skye Bioscience, Inc. (SKYE)
2.02
-0.15
(-6.91%)
USD |
NASDAQ |
Aug 25, 15:49
Skye Bioscience Total Assets (Quarterly) : 11.03M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.03M |
| March 31, 2026 | 19.42M |
| December 31, 2025 | 28.31M |
| September 30, 2025 | 41.32M |
| June 30, 2025 | 52.16M |
| March 31, 2025 | 64.79M |
| December 31, 2024 | 72.76M |
| September 30, 2024 | 81.54M |
| June 30, 2024 | 87.26M |
| March 31, 2024 | 94.84M |
| December 31, 2023 | 11.94M |
| September 30, 2023 | 15.60M |
| June 30, 2023 | 2.236M |
| March 31, 2023 | 4.587M |
| December 31, 2022 | 9.111M |
| September 30, 2022 | 2.869M |
| June 30, 2022 | 4.968M |
| March 31, 2022 | 7.211M |
| December 31, 2021 | 9.855M |
| September 30, 2021 | 11.69M |
| June 30, 2021 | 5.488M |
| March 31, 2021 | 5.399M |
| December 31, 2020 | 2.672M |
| September 30, 2020 | 4.350M |
| June 30, 2020 | 0.2272M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.673M |
| December 31, 2019 | 1.997M |
| September 30, 2019 | 1.725M |
| June 30, 2019 | 3.080M |
| March 31, 2019 | 4.725M |
| December 31, 2018 | 1.957M |
| September 30, 2018 | 1.166M |
| June 30, 2018 | 2.042M |
| March 31, 2018 | 3.158M |
| December 31, 2017 | 0.5572M |
| September 30, 2017 | 0.343M |
| June 30, 2017 | 0.484M |
| March 31, 2017 | 0.6174M |
| December 31, 2016 | 0.3234M |
| September 30, 2016 | 0.6921M |
| June 30, 2016 | 1.081M |
| March 31, 2016 | 2.350M |
| December 31, 2015 | 3.511M |
| September 30, 2015 | 4.542M |
| June 30, 2015 | 0.8208M |
| March 31, 2015 | 0.4687M |
| December 31, 2014 | 0.3483M |
| September 30, 2014 | 1.126M |
| April 30, 2014 | 0.1227M |
| January 31, 2014 | 0.1408M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| Viking Therapeutics, Inc. | 521.90M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.53M |
| Shareholders Equity (Quarterly) | -0.4973M |
| Debt to Equity Ratio | -0.3593 |
| Current Ratio | 0.9504 |
| Net Debt Paydown Yield | 0.19% |